Skip to content

James S. Goodwin, MD

Dr. James S. Goodwin, MD

George & Cynthia Mitchell Distinguished Chair in
Geriatric Medicine
Director, Sealy Center on Aging

Contact Information:
The University of Texas Medical Branch
Galveston, Texas 77555-0460
Phone: (409) 747-1987
FAX:(409) 747-3585
E-mail: jsgoodwi@utmb.edu

Dr. Goodwin's essays from the Lancet

Medical School: Harvard Medical School, Boston, MA. 1971
Internship: Harbor General Hospital, Torrance, CA, 1971-72
Residency: Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 1974-76
Fellowship: Rheumatology, University of New Mexico School of Medicine, Albuquerque, NM, 1976-78

Board Certification:

1976 The American Board of Internal Medicine
1978 Rheumatology Subspecialty Board
2000 Geriatric Medicine

Licensure: State of Texas

Professional Experience: Clinical

1971 to 1972 Intern, Harbor General Hospital, Torrance, CA
1974 to 1976 Resident, Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM
1976 to 1978 Fellow in Rheumatology, University of New Mexico School of Medicine, Albuquerque, NM
1978 to 1981 Assistant Professor of Medicine, University of New Mexico School of Medicine, Albuquerque, NM
1981 to 1985 Associate Professor of Medicine, University of New Mexico School of Medicine, Albuquerque, NM
1985 to 1988 Professor and Vice Chairman, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
1988 to 1992 Professor of Medicine and Chief of Geriatrics, University of Wisconsin, Milwaukee Campus, Milwaukee, WI
1988 to 1992 Director, Sinai Samaritan Geriatrics Institute, Milwaukee, WI
1992 to Present

1992 to Present


1996-1999

1999 to 2003 		Director, Sealy Center on Aging

George and Cynthia Mitchell Distinguished Professor of Medicine and Chief of Geriatrics, The University of Texas Medical Branch, Galveston, TX

Medical Director, Senior Services Office, The University of Texas Medical Branch

Chief Medical Officer, Geriatric Service Line, The University of Texas Medical Branch, Galveston, TX
1994 to Present Professor of Nursing, UTMB School of Nursing, The University of Texas Medical Branch, Galveston, TX
1994 to Present Professor of Preventive Medicine and Community Health, The University of Texas Medical Branch, Galveston, TX

RESEARCH ACTIVITIES:

CURRENT AREAS OF RESEARCH:

Patterns of cancer care in the elderly
Barriers to health care delivery in the elderly
Predictors of physical functioning and health in older populations

GRANT SUPPORT:

Principal Investigator - (current):

Sealy and Smith Foundation. Support for Sealy Center on Aging. 20% time, $13,150,000 (total costs), 9/1/95-8/31/10.

NIH-T32AG00270. Health of Older Minorities (pre and post doctoral training grant). 5% time, $822,824 (direct costs), 7/1/99 - 6/30/09.

NIH-P60AG17231. UTMB Claude Pepper Older American Independence Center. 20% time, $14,728,000 (total costs), 2/01/00 - 1/31/10.

NIH-5P50CA105631. UTMB Center for Population Health and Health Disparities. 25% time. $9,276,581 (total costs). 9/01/03 - 8/31/08

NIH - RO1 - CA104949. Use of claims data to study quality of cancer care. 20% time. $792,000 (total cost). 5/01/04 - 04/20/08.

Komen Foundation. Breast Cancer in Hispanic Women. 5% time. $250,000 (total costs). 07/01/06-06/30/08.

Co-Investigator - (current):

AG-10939 - A Longitudinal Study of Mexican-American Elderly Health. (K. Markides, PI)$6,920,000 (total costs for 1998-2009). 5% time. 9/30/92 - 6/30/09.

CA-HS-08554 - Evaluating Mammography Claims Data (J. Freeman, PI). 5% time. $1,720,000 (total costs for 1999-07). 9/30/96 - 9/29/07.

R24-HS11618 - Health Services Research in Underserved Populations (J. Freeman, PI), 5% time, $1,906,900 (total costs), 9/30/01 - 9/29/07.

T35-AG026778 - Summer Research Training in Aging for Medical Students (S. Studenski, PI), 3% time, $145,475 (total costs), 06/01/05-05/31/08.

Principal Investigator - (prior funding):

NIAID AII4838 - "Young Investigator Award" - Suppressor Cell Activity in Human Peripheral Blood $270,000 (direct costs) 4/1/78 - 3/30/81

NIH AG01245 - Role of Prostaglandins in the Immunobiology of Aging $1,240,000 (direct costs) 12/1/78 - 11/30/83; $632,454 (direct costs) 12/1/83 - 11/30/89 (40% time).

AM 34672 - Role of Leukotrienes in Humoral and Cellular Immunity $270,000 (direct costs) 12/1/84 - 11/30/88 (20% time).

CA 36592 - Patterns of Cancer Care in Elderly New Mexicans $280,000 (direct costs) 4/1/84 - 3/31/87 (15% time, co-principal investigator with J. Samet).

Dreyfus Foundation support for book writing - $5,000 open termination.

Pfizer International - Effect of Piroxicam in Vivo on Immunologic Function $125,000 total, 9/1/81 - 8/30/84.

AARP-NRTA Andrus Foundation - Effect of Subclinical Malnutrition on Cognitive Function in the Elderly. $120,000 total costs, 7/1/81 - 6/30/84.

ITT-Continental Baking Company - Prospective Study of the Effect of Major Life Changes on Human Nutrition, Co-Principal Investigator $50,000 total costs, 7/1/81 - 6/30/83.

Searle, Inc. - Effect of Oral Prostaglandin Analogues on Immunologic Function in Healthy Elderly Subjects $55,000, 1/1/83 - 12/30/87.

NIA AG02049 - A Prospective Study of Nutrition in the Elderly $533,117 (direct costs) 2/1/79 - 11/30/84 (principal investigator 20% time); $420,000 (direct costs) 1/1/84 -11/30/87 (co-investigator).

Searle Prostaglandin Challenge grant - Role of arachidonic acid metabolites in signal transduction for IL-1. 20% time, $250,000 (direct costs), 7/1/91 - 6/30/93, principal investigator.

NIH-NR-03243. Barriers to breast cancer in older women. 20% time, $892,000 (direct costs), 9/1/92 - 8/31/96.

Pew Charitable Trust. Health of the Public Initiative. 10% time, $250,000 (direct costs), 10/1/93-3/30/97.

U.S. Army. BC962107 - The elevated breast cancer mortality in the Northeastern U.S. is secondary to poorer survival rather than increased incidence. 25% time, $300,000 (total costs), 4/1/97 - 10/31/99.

NIH-AG 00618. Geriatric Leadership Academic Award. 25% time, $480,000 (direct costs). 4/20/94 - 2/28/01.

NIH-CA 871773. Variations in Breast Cancer Treatment and Mortality. 15% time, $843,307 (direct costs), 4/1/99 - 3/31/04.

AAMC/Hartford Foundation. Enhancing Gerontology and Geriatric Medical Education in Undergraduate Medical Education. 10% time, $100,000, 7/01/00 - 6/30/03.

Hartford Foundation. Emerging Center of Excellence. 5% time, $200,000, 7/01/02 - 6/30/04.

Arthur Vining Davis Foundations. Enhancing End of Life Education for Health Care Professionals. $142,800 (Total costs), 7/01/02 - 6/30/06.

HRSA-D31HP80023. East Texas Geriatric Education Center. 10% time. $1,000,000 (total costs), 12/31/06.

PUBLICATIONS

ARTICLES IN PEER-REVIEWED JOURNALS

  1. Brot N, Goodwin J and Fales H: In vivo and in vitro formation of 2, 3-dihydroxybenzoylerine by Escherichia coli K12. Biochem Biophys Res Comm, 1966; 25:454-61.
  2. Brot N and Goodwin J: Regulation of 2, 3-dihydroxybenzoylserine synthetase by iron. J Biol Chem, 1968; 243:510-13.
  3. Goodwin JS, Katz RI and Kopin IJ: Effect of bromide on evoked release of monoamines from brain slices and intact atria. Nature, 1969; 221:556-57.
  4. Katz RI, Goodwin JS and Kopin IJ: Disposition of neuro-transmitters in experimental mouse glioma. Life Sci, 1969; 8(1):561-69.
  5. Goodwin JS, Bankhurst AD and Messner RP: Suppression of human T-cell mitogenesis by prostaglandin: Existence of a prostaglandin-producing suppressor cell. J Exp Med, 1977; 146: 1719-34.
  6. Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH and Williams RC, Jr.
    Prostaglandin-producing suppressor cells in Hodgkin's disease. New Eng J Med, 1977;
    297:963-68.
  7. Goodwin JS, Messner RP and Peake GT: Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro: Changes with mitogen dose and preincubation. J Clin Invest, 1978; 62:
    753-60.
  8. Goodwin JS, Selinger DS, Messner RP and Reed WP: Effect of indomethacin in vivo on humoral and cellular immunity in humans. Infect Immun, 1978; 19:430-33.
  9. Goodwin JS and Messner RP: Prostaglandin E inhibition of mitogen stimulation in patients with multiple sclerosis. Prostaglandins, 1978; 15:281-86.
  10. Jensen RT, Van Epps DE, Goodwin JS and Bowerman J: Incontinentia pigmenti: Evidence for both neutrophil and lymphocyte dysfunction. Arch Dermatol, 1978; 114:1182-86.
  11. Goodwin JS, Bankhurst AD, Murphy SA, Selinger DS, Messner RP and Williams RC, Jr: Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin. J Clin Lab Immunol, 1978; 1:197-99.
  12. Van Epps DE, Goodwin JS and Murphy S: Age-dependent variations in polymorphonuclear leukocyte chemiluminescence. Infect Immun, 1978; 22:57-61.
  13. Goodwin JS, DeHoratius R, Isreal H, Peake GT and Messner RP: Suppressor cell function in sarcoidosis. Ann Int Med, 1979; 90:169-73.
  14. Goodwin JS, Wiik A. Lewis M, Bankhurst AD and Williams RC, Jr: High affinity binding sites for prostaglandin E on human lymphocytes. Cell Immunol, 1979; 43:150-59.
  15. Goodwin JM, Goodwin JS and Kellner R: Psychiatric symptoms in disliked medical patients. JAMA, 1979; 241:1117-20.
  16. Echols RM, Selinger DS, Hallowell C, Goodwin JS, Duncan MH and Cushing AH: Rhizopus osteomyelititis: A case report and review. Am J Med, 1979; 66:141-45.
  17. Goodwin JS, Messner RP and Williams RC, Jr: Inhibitors of T cell mitogenesis: Effect of mitogen dose. Cell Immunol, 1979; 45:303-8.
  18. Goodwin JS and Messner RP: Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70. J Clin Invest, 1979; 64:434-39.
  19. Goodwin JS and Goodwin JM: Cerebritis in lupus erythematosus. Ann Int Med, 1979; 90:437-38.
  20. Goodwin JS, Goodwin JM and Vogel AV: Knowledge and Use of Placebos by House Officers and Nurses. Ann Int Med, 1979; 91:106-10.
  21. Goldberg EH, Goodwin JS, Arritt SE and Williams RC, Jr: Prolongation of male skin graft survival by female mice treated with cimetidine. Transplantation, 1979; 28:432-33.
  22. Goodwin JS: Increased sensitivity to prostaglandin E2 in old people. Prostaglandin Med, 1979; 3:395-400.
  23. Goodwin JS, Kaszbowski PA and Williams RC, Jr: Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes. J Exp Med, 1979; 150:1260-64.
  24. Goodwin JS: Modulation of concanavalin-A-induced suppressor cell activation by prostaglandin E2. Cell Immunol, 1980; 49:421-25.
  25. Kaszubowski PA, Goodwin JS and Williams RC, Jr: Ia Antigen on the surface of a subfraction of T cells that bear Fc receptors for IgG. J Immunol, 1980; 124:1075-78.
  26. Staszak C, Goodwin JS, Troup GM, Pathak DR and Williams RC, Jr: Decreased sensitivity to prostaglandin and histamine in lymphocytes from normal HLA-B12 individuals: A possible role in autoimmunity. J Immunol, 1980; 125:181-85.
  27. Bankhurst AD, Kauffman GR, Goodwin JS, Saiki JH, Saiers JH and Williams RC, Jr: Suppressor Leukocytes in anergic patients with solid tumors. J Clin Lab Immunol, 1980; 3:159-63.
  28. Wolinsky SI, Goodwin JS, Messner RP and Williams RC, Jr: Role of prostaglandin in the depressed cell-mediated immune response in rheumatoid arthritis. Clin Immunol Immunopathol, 1980; 17:31-37.
  29. Goodwin JS: Prostaglandin regulation of mitogenesis. Cell Immunol, 1980; 52:239-40.
  30. Staszak C and Goodwin JS: Is prostaglandin a mediator for the inhibitory action of histamine, hydrocortisone, and isoproterenol? Cell Immunol, 1980; 54:351-61.
  31. Froelich CJ, Searles RP, Davis LE and Goodwin JS: A case of Guillain-Barre Syndrome with immunologic abnormalities. Ann Int Med; 1980; 93:563-65.
  32. Goodwin JS: Remission in systemic lupus erythematosus after combination chemotherapy for Hodgkin's disease. JAMA, 1980; 244:1962.
  33. Bankhurst AD, Hastain E, Goodwin JS and Peake GT: The nature of the prostaglandin-producing mononuclear cell in human peripheral blood. J Lab Clin Med, 1981; 97:179-86.
  34. Goodwin JS, Bromberg S and Messner RP: Studies on the cyclic AMP response to prostaglandin in human lymphocytes. Cell Immunol, 1981; 60:298-307.
  35. Goodwin JS and Goodwin JM: Failure to recognize efficacious treatments: A history of salicylate therapy in rheumatoid arthritis. Perspect Biol Med, 1981; 25:78-92.
  36. Lafferty WE, Kempf RA, and Goodwin JS: Suppression of lymphocyte proliferation by human tumor cells grown in short term cultures. J Clin Lab Immunol, 1981; 6:157-63.
  37. Goodwin JS: OKT3, OKT4 and all that. JAMA, 1981; 246:947-48.
  38. Goodwin JS, Bromberg S, Staszak C, Kaszubowski PA, Messner RP and Neale JF: Effect of physical stress on sensitivity of lymphocytes to inhibition by prostaglandin E2. J Immunol, 1981; 127:518-22.
  39. Ceuppens JL, Goodwin JS and Searles RP: The presence of Ia antigen on human peripheral blood T cells and T-cell subsets: Analysis with monoclonal antibodies and the fluorescence-activated cell sorter. Cell Immunol, 1981; 64:277-92.
  40. Lafferty WP, Selinger DS, Schiffman G and Goodwin JS:  Response to pneumococcal vaccine in the elderly:  No enhancement by indomethacin.  J Immunopharmacol, 1981; 3:241-51.
  41. Comstock LM, Hooper EM, Goodwin JM and Goodwin JS: Physician behaviors that correlate with patient satisfaction. J Med Educ, 1982; 57:105-12.
  42. Hooper EM, Comstock LM, Goodwin JM and Goodwin JS: Patient characteristics that influence physician behavior. Med Care, 1982; 20:630-38.
  43. Okudaira K, Searles RP, Ceuppens JL, Goodwin JS and Williams RC, Jr: Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest, 1982; 69:17-24.
  44. Ceuppens JL, Gualde N and Goodwin JS: Phenotypic heterogeneity of the OKM1-positive lymphocyte population: Reactivity of the OKM1 monoclonal antibody with a subset of the suppressor/cytotoxic T-cell population. Cell Immunol, 1982; 69:150-65.
  45. Goodwin JS and Regan M: Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum, 1982; 25:1013-15.
  46. Garry PJ, Goodwin JS, Hunt WC, Hooper EM and Leonard AG: Nutritional status in a healthy elderly population: Dietary and supplemental intakes. Am J Clin Nutr, 1982; 36:319-31.
  47. Ceuppens JL, Rodriguez MA and Goodwin JS: Non-steroidal anti-inflammatory agents inhibit the synthesis of IgM rheumatoid factor in vitro. Lancet, 1982; 1:528-30.
  48. Goodwin JS, Searles RP and Tung KSK: Immunological responses of a healthy elderly population. Clin Exp Immunol, 1982; 48:403-10.
  49. Kaszubowski PA and Goodwin JS: Monocyte-produced prostaglandin induces Fc receptor expression on human T cells. Cell Immunol, 1982; 68:343-48.
  50. Ceuppens JL and Goodwin JS: Endogenous prostaglandin E2 enhances polyclonal Immunoglobulin production by tonically inhibiting T suppressor cell activity. Cell Immunol, 1982; 70:41-54.
  51. Rodriquez MA, Ceuppens JL and Goodwin JS: Regulation of IgM rheumatoid factor production in lymphocyte cultures from young and old subjects. J Immunol, 1982; 128:2422-28.
  52. Ceuppens JL and Goodwin JS: Regulation of immunoglobin production in pokeweed mitogen-stimulated cultures of lymphocytes from young and old adults. J Immunol, 1982; 128:2429-34.
  53. Garry PJ, Goodwin JS, Hunt WC and Gilbert BA: Nutritional status in a healthy elderly population: Vitamin C. Am J Clin Nutr, 1982; 36:332-39.
  54. Okudaira K, Searles RP, Goodwin JS and Williams RC, Jr: Antibodies in the sera of patients with systemic lupus erythematosus that block the binding of monoclonal anti-Ia to Ia-positive targets also inhibit the autologous mixed lymphocyte response. J Immunol, 1982; 129:582-86.
  55. Goodwin JS: Changes in lymphocyte sensitivity to prostaglandin E, histamine, hydrocortisone, and x-irradiation with age: Studies in a healthy elderly population. Clin Immunol Immunopathol, 1982; 25:243-51.
  56. Okudaira K, Goodwin JS and Williams RC, Jr: Anti-Ia antibody in the sera of normal subjects after in vivo antigenic stimulation. J Exp Med, 1982; 156:255-67.
  57. Garry PJ, Goodwin JS and Hunt WC: Nutritional status in a healthy elderly population: Riboflavin. Am J Clin Nutr, 1982; 36:902-909.
  58. Omdahl JL, Garry PJ, Hunsacker LA, Hunt WC and Goodwin JS: Nutritional status in the healthy elderly population: Vitamin D. Am J Clin Nutr, 1982; 36:1225-33.
  59. Gualde N and Goodwin JS: Effects of prostaglandin E2 and preincubation on lectin-stimulated proliferation on human T cell subsets. Cell Immunol, 1982; 70:373-79.
  60. Hooper PL, Garry PJ, Goodwin JS, Hooper EM and Leonard AG: High-density lipoprotein-cholesterol and diet in a healthy elderly population. J Am Coll Nutr, 1982; 1:337-43.
  61. Thomas PD, Hunt WC, Garry PJ, Hood RB, Goodwin JM and Goodwin JS: Hearing acuity in a healthy elderly population: Effects on emotional, cognitive, and social status. J Gerontol, 1983; 38:321-25.
  62. Goodwin JS and Garry PJ: Non-relationship between megadose vitamin supplementation and immunological function in a healthy elderly population. Clin Exp Immunol, 1983; 51:647-53.
  63. Goodwin JS, Goodwin JM and Garry PJ: Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA, 1983; 249:2917-21.
  64. Searles RP, Okudaira K, Savage SM and Goodwin JS: Ia Specific antilymphocyte antibodies in rheumatoid arthritis. Arthritis Rheum, 1983; 26:486-93.
  65. Garry PJ, Goodwin JS and Hunt WC: Iron status and anemia in the elderly: New findings and a review of previous studies. J Am Geriatr Soc, 1983; 31:389-99.
  66. Hunt WC, Leonard AG, Garry PJ and Goodwin JS: Components of variance in dietary data for an elderly population. Nutr Res, 1983; 3:433-44.
  67. Goodwin JS: Old people in hospitals. J Chron Dis, 1983; 36:661-62.
  68. Goodwin JS, Ceuppens JL and Rodriguez MA: Administration of non-steroidal anti-inflammatory agents in patients with rheumatoid arthritis: Effects on indices of cellular immune status and serum rheumatoid factor levels. JAMA, 1983; 250:2485-88.
  69. Haaland KY, Linn RT, Hunt WC and Goodwin JS: A normative study of Russell's variant of the Wechsler Memory Scale in a healthy elderly population. J Consult Clin Psychol, 1983; 51:878-81.
  70. Hooper PL, Hooper EM, Hunt WC, Garry PJ and Goodwin JS: Vitamins, lipids and lipoproteins in a healthy elderly population. Int J Vit Nutr Res, 1983; 53:412-19.
  71. Goodwin JS and Goodwin JM: The tomato effect: Rejection of highly efficacious therapies. JAMA, 1984; 251:2387-90.
  72. Sanchez CJ, Hooper E, Garry PJ, Goodwin JM and Goodwin JS: The relationship between dietary intake of choline, serum choline levels and cognitive function in healthy elderly persons. J Am Geriatr Soc, 1984; 32:208-12.
  73. Goodwin JS, Gualde N, Aldigier J, Rigaud M and Vanderhoek JY: Modulation of Fc receptors on T cells and monocytes by 15 hydroperoxyeicosatetraenoic acid. Prostaglandins Leukotrienes Med, 1984; 13:109-12.
  74. Gualde N and Goodwin JS: Effect of irradiation on human T-cell proliferation: Low dose irradiation stimulates mitogen-induced proliferation and function of the suppressor/cytotoxic T cell subset. Cell Immunol, 1984; 84:439-45.
  75. Garry PJ, Goodwin JS and Hunt WC: Folate and vitamin B12 status in a healthy elderly population. J Am Geriatr Soc, 1984; 32:719-26.
  76. Atluru D and Goodwin JS: Control of polyclonal immunoglobulin production from human lymphocytes by leukotrienes; LTB4 induces an OKT8 (+) radiosensitive suppressor cell from resting, human OKT8 (-) T cells. J Clin Invest, 1984; 74:1444-50.
  77. Rosenthal M and Goodwin JS: A case of hyperthyroidism presenting as recurrent pneumonia. West J Med, 1985; 142:550-52.
  78. Goodwin JS, Leonard AG, Hooper EM and Garry PJ: Concern about cholesterol and its association with diet in a group of healthy elderly. Nutr Res, 1985; 5:141-48.
  79. Thomas PD, Garry PJ, Goodwin JM and Goodwin JS: Social bonds in a healthy elderly sample: Characteristics and associated variables. Soc Sci Med, 1985; 20:365.
  80. Gualde JS, Atluru D and Goodwin JS: Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets. J Immunol, 1985; 134:1125-29.
  81. Goodwin JS, Hunt WC, Hooper P and Garry PJ: Relationship between zinc intake, physical activity and blood levels of high density lipoprotein cholesterol in a healthy elderly population. Metabolism, 1985; 34:519-23.
  82. Koster F, Williams RC and Goodwin JS: Cellular immunity in Q fever: Modulation of responsiveness by a suppressor T cell-monocyte circuit. J Immunol, 1985; 135:1067-72.
  83. Goodwin JS and Goodwin JM: CPR. J Chron Dis, 1985; 38:717-19.
  84. Thomas PD, Goodwin JM and Goodwin JS: Social support and decreased stress-related changes in cholesterol, uric acid and immune function in an elderly sample. Am J Psychiatry, 1985; 142:
    735-38.
  85. Silvestris F, Anderson W, Goodwin JS and Williams RC, Jr: Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol, 1985; 35:234-44.
  86. Silvestris F, Goodwin JS, Williams RC, Jr: IgM, IgA, and IgG rheumatoid factors in patients with rheumatoid arthritis and normal donors. Clin Rheumatol, 1985; 4:392-98.
  87. Gualde N, Rigaud M and Goodwin JS: Induction of suppressor cells from human peripheral blood T cells by 15-hydroperoxyeicosatetranoic acid (15-HPETE). J Immunol, 1985; 135:3424-29.
  88. Alexander N and Goodwin JS: Comparison of admission and discharge medications in two geriatric populations. J Am Geriatr Soc, 1985; 33:827-32.
  89. Koster FK, Williams JC and Goodwin JS: Cellular immunity in Q fever: Specific lymphocyte unresponsiveness in Q fever endocarditis. J Inf Dis, 1985; 152:1283-89.
  90. Goodwin JS, Atluru D, Sierakowski and Lianos E: Mechanism of action of glucocorticosteroids: Inhibition of T cell proliferation and interleukin-2 production by hydrocortisone is reversed by leukotriene B4. J Clin Invest, 1986; 77:1244-50.
  91. Goodwin JS and Atluru D: Mechanism of action of glucocorticoid-induced immunoglobulin production: Role of lipoxygenase metabolites of arachidonic acid. J Immunol, 1986; 136: 3455-60.
  92. Atluru D and Goodwin JS: Leukotriene B4 causes proliferation of interleukin 2 dependent T cells in the presence of suboptimal concentrations of interleukin-2. Cell Immunol, 1986; 99:444-52.
  93. Atluru D and Goodwin JS: Regulation of phytohemagglutinin-induced bovine lymphocyte blastogenesis by leukotrienes. Am J Vet Res, 1986; 47:1963-66.
  94. Goodwin JS, Samet JM and Key CR: Stage at diagnosis of cancer varies with the age of the patient. J Am Geriat Soc, 1986; 34:20-26.
  95. Samet J, Key C, Hunt C and Goodwin JS: Choice of cancer therapy varies with the age of the patient. JAMA, 1986; 255:3385-90.
  96. Thomas P, Garry PJ and Goodwin JS: Morbidity and mortality in an initially healthy elderly sample: Findings after five years of follow-up. Age and Aging, 1986; 15:105-10.
  97. Goodwin JS and Clay GA: Effect of chronic ingestion of a prostaglandin E analogue on immunologic function in healthy elderly subjects. Int J Immunopharmacol, 1986; 8:867-73.
  98. Atluru D, Lianos E and Goodwin JS: Arachidonic acid inhibits 5-lipoxygenase in human T cells. Biochem Biophys Res Comm, 1986; 135:670-76.
  99. Haaland KV, Vranes LF, Garry PJ and Goodwin JS: Wisconsin card sort test in a healthy elderly population. J Gerontology, 1987; 42:345-46.
  100. Mann B, Garry P, Hunt C and Goodwin JS:  Effect of multivitamin supplementation on blood vitamin levels in the elderly:  A prospective, placebo controlled, double-blind trial.  J Am Geriatric Soc, 1987; 35:290-96.
  101. Thomas P and Goodwin JS: Diagnostic importance of an elevated erythrocyte sedimentation rate in the elderly. Clinical Rheumatology, 1987; 6:177-80.
  102. Goodwin JS, Sanchez CJ, Thomas P, and Goodwin JM: Alcohol intake in a healthy elderly population. Am J Public Health, 1987; 77:173-77.
  103. Van Epps D, Griewe S, Potter J and Goodwin JS: Alterations in neutrophil superoxide production following piroxicam therapy in patients with rheumatoid arthritis. Inflammation, 1987; 11:59-72.
  104. Ming RH, Atluru D, Spellman CW, Imir T, Goodwin JS and Strickland RG: Peripheral blood mononuclear cell interleukin-production, receptor generation and lymphokine activated cytotoxicity in inflammatory bowel disease. J Clin Immunol, 1987; 7:59-63.
  105. Willis L, Thomas P, Garry PJ and Goodwin JS: A prospective study of behavioral and immunoendocrine responses to stressful life events in initially healthy elders. J Gerontology, 1987; 42:627-30.
  106. Goodwin JS, Hunt C, Key C and Samet J: Relationship of marital status to stage at diagnosis, choice of treatment and survival in individuals with cancer. JAMA, 1987; 258:3125-30.
  107. Samet J, Key C, Hunt WC and Goodwin JS: Survival of American Indian and Hispanic Cancer patients in New Mexico and Arizona, 1969-1982. J Nat Cancer Instit, 1987; 79:457-63.
  108. Rosenthal MJ, Hunt WC, Garry PJ and Goodwin JS: Natural history of thyroid failure in the elderly. JAMA, 1987; 258:209-13.
  109. Garry PJ, Hunt WC, Bandrofahak JL, VanderJagt D and Goodwin JS: Vitamin A intake and plasma Retinol levels in healthy elderly men and women. Am J Clin Nutrition, 1987; 46:989-94.
  110. Sierakowski S, Kucharz E, Lightfoot R and Goodwin JS: Impaired Interleukin-1 production in systemic lupus erythematosus. Clin Rheumatology, 1987; 6:403-7.
  111. Kucharz E, Sierakowski S and Goodwin JS: Decreased activity of interleukin-2 inhibitor in plasma of patients with systemic lupus erythematosus. Clin Rheumatol, 1987; 6:87-90.
  112. Goodwin JS and Garry PJ: Lack of effect of subclinical malnutrition on immune function in healthy elderly adults. J Gerontol, 1988; 43:46-50.
  113. Sierakowski S and Goodwin JS: Mechanism of action of glucocorticoid-induced immunoglobulin production. II. Requirement for fetal calf sera. Clin Exp Immunol, 1988; 71:198-210.
  114. Mann B, Samet J, Key C, Goodwin JM and Goodwin JS: Changing treatment of breast cancer in New Mexico from 1969 through 1985. JAMA, 1988; 259:3413-2417.
  115. Kucharz E and Goodwin JS: Mechanism of lithium augmentation of T cell proliferation. Int J Immunopharm, 1988; 10:253-60.
  116. Samet JM, Hunt WC, Lerchen ML and Goodwin JS: Delay in seeking care for cancer symptoms: A population-based study of elderly New Mexicans. J Nat Cancer Instit, 1988; 80:432-38.
  117. Goodwin JS, Hunt WC, Key CR and Samet J: Cancer treatment protocols: Who gets chosen? Archiv Int Med, 1988; 148:2258-60.
  118. Goodwin JS and Goodwin JM: The use of cement controls in evaluating assumptions about etiology and mechanism of action. J Clinic Epidemiol, 1988; 1:803-804.
  119. Burke HL, Yeo RA, Vranej L, Garry PJ and Goodwin JS: Handedness, developmental disorders, and in vivo measurements of immune responses. Developmental Neuropsychology, 1988; 4:103-15.
  120. Becker TM, Hunt WC, Goodwin JS, Key CR and Samet JM: Short-term survival after cancer surgery in the elderly: Time trends and the effects of age. J Am Geriat Soc, 1989; 37:155-59.
  121. Sierakowski S, Kucharz E, Lightfoot R and Goodwin JS: Impaired T cell activation in patients with systemic lupus erythematosus. J Clin Immunol, 1989; 9:469-76.
  122. Goodwin JS: Knowledge about aging among physicians. J Aging Health, 1989; 1:234-43.
  123. Kucharz EJ and Goodwin JS: Dibutyryl guanosine cyclic monophosphate causes proliferation of interleukin 2 dependent T cells in the presence of suboptimal levels of interleukin 2. Int J Immunopharmacol, 1989; 11:687-90.
  124. Behrens T, Lum L and Goodwin JS: Lipoxygenase inhibitors enhance the proliferation of human B cells. J Immunol, 1989; 143:2285-94.
  125. Liang S, Ledbetter J and Goodwin JS: Phosphotidyl inositol hydrolysis after CD3 binding in human peripheral blood T cells: Inhibition by prostaglandin E2. Int J Immunopharmacol, 1989; 11:809-16.
  126. Goodwin JS, Hunt WC, Key CR and Samet JM: Changes in Surgical treatments: The example of hysterectomy versus conization for cervical carcinoma in situ. J Clin Epidemiol, 1990; 43:977-82.
  127. Burns EA, Lum L, Fiddings B, Seigneuret M and Goodwin JS: Decreased specific antibody synthesis by lymphocytes from elderly subjects. Mech Aging and Dev, 1990; 53:229-41.
  128. Behrens T and Goodwin JS: Platelet-activating factor modulates human T cell proliferation. Int J Immunopharmacol, 1990; 12:175-84.
  129. Kucharz EJ and Goodwin JS: Hydralazine causes non-specific binding of antibodies to human lymphocytes in vitro. Immunopharmacol, 1990; 19:1-4.
  130. Wayne S, Rhyne R, Garry PJ and Goodwin JS: Cell-mediated immunity as a predictor of morbidity and mortality in the aged. J Gerontology, 1990; 45:M45-49.
  131. Samet J, Hunt WC and Goodwin JS: Determinants of cancer stage: a population-based study of elderly New Mexicans. Cancer, 1990; 66:1302-07.
  132. Adams W, Hunt WC, Rhyne R, Garry PJ and Goodwin JS: Change in alcohol intake with age: a longitudinal and cross-sectional study. J Am Geriat Soc, 1990; 38:211-16.
  133. Goodwin JS: The very low prevalence of polymyalgia rheumatica in blacks may be an artifact. J Am Geriat Soc, 1990; 38:824-26.
  134. Harford AM, Shopp GM and Goodwin JS et al. Murine Thymocyte Lysis by Inhibitors of Arachidonic Acid Metabolism. Adv Prost Throm Leuk Res, 1990; 21:489-92.
  135. Goodwin JS: Mercy killing, JAMA, 1991; 265:326.
  136. Kane R and Goodwin JS: Spontaneous fractures in the nursing home. Am J Med, 1991; 40:263-66.
  137. Klos S, Drinka P, Goodwin J: Fecal occult blood testing in the nursing home. J Am Geriat Soc, 1991; 39:1169-73.
  138. Malone M, Rozario N, Gavinski M and Goodwin JS: The epidemiology of skin tears in a nursing home. J Am Geriat Soc, 1991; 39:591-95.
  139. Goodwin JS, Hunt WC and Samet JM: A population-based study of functional status and social support of elderly patients newly diagnosed with cancer. Archives Int Med, 1991; 151:366-70.
  140. Goodwin JS: The empirical basis for the discovery of new therapies. Perspectives in Biology and Medicine, 1991; 35:20-36.
  141. Gennis V, Garry P, Haaland K, Yeo RA and Goodwin JS: Hearing and cognitive status in the elderly. Archiv Intern Med, 1991; 151:2259-64.
  142. Goodwin JS: Geriatric ideology: The myth of the myth of senility. J Am Geriat Soc 39:627-631, 1991. Also translated into German in Intercura, 1992; 37:40-52. Also reprinted in Aging and Everyday Life, J.F. Bubrium and J.A. Holstein, editors, Blackwell Publishers, Oxford, UK, 2000, pp 331-39.
  143. Nattinger A, Gottlieb MS, Veum J, Yahnke D and Goodwin JS: Regional variation in use of breast-conserving surgery in women with localized breast cancer. New Engl J Med, 1992; 326:1102-07.
  144. Nattinger A and Goodwin JS: Screening mammography in elderly women: a case of mixed messages. Archiv Int Med, 1992; 152:922-25.
  145. Malone ML, Klos SM, Gennis VM and Goodwin JS: Frequent hypoglycemic episodes in the management of patients with diabetic ketoacidosis. Archiv Int Med, 1992; 152:2472-77.
  146. Malone ML, Gennis VM and Goodwin JS: Diabetic ketoacidosis in the elderly. J Am Geriat Soc, 1992; 40:1100-04.
  147. Drinka P and Goodwin JS: Serum Folate levels in nursing home patients. J. Am Coll. Nutrit, 1993; 12:186-89.
  148. Goodwin JS, Hunt WC and Samet JM: Determinants of choice of cancer therapy in elderly patients: results from a population-based study. Cancer, 1993; 72:594-602.
  149. Burns EA, Lum LG, L'Hommedieu G and Goodwin JS: Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination. J Gerontol, 1993; 48:B231-B236.
  150. Malone ML, Thompson L, Goodwin JS.  Aggressive behavior among institutionalized elderly.  J Am Geriatr Soc, 1993; 41:853-56.
  151. Kucharz EJ, Sierakowski SJ, Goodwin JS. Lithium in vitro enhances interleukin 2 production by T cells from patients with systemic lupus erythematosus. Immunopharmacol Immunotoxicol, 1993; 15:515-23.
  152. Sial S, Malone M, Freeman JL, Battiola R, Nachodsky J, Goodwin JS. Beta blocker use in community hospital patients discharged after myocardial infarction. J Gen Int Med, 1994; 9:599-605.
  153. Burns EA, L'Hommedieu GD, Cunning JL, Goodwin JS. Effects of interleukin 4 on antigen specific antibody synthesis by lymphocytes from old and young adults. Lymphokine and Cytokine Research, 1994; 13:227-31.
  154. Buckler DA, Kelber ST, Goodwin JS. The use of dietary restrictions in malnourished nursing home patients. J Am Geriatr Soc, 1994; 42:1100-02.
  155. Malone ML, Sial S, Battiola RJ, Nachodsky JP, Solomon DJ, Goodwin JS. Age related differences in the utilization of therapies post-acute myocardial infarction. J Am Geriatr Soc, 1995; 43:627-33.
  156. Kane RS, Burns EA, Goodwin JS. Minimal trauma fractures in older nursing home residents: the interaction of functional status, trauma and site of fracture. J Am Geriatr Soc, 1995; 43:156-59.
  157. Goodwin JS. Culture and medicine: The influence of Puritanism on American Medical Practice. Perspectives in Biology and Medicine, 1995, 38:567-77.
  158. Goodwin JS, Nattinger AB. Effect of season and climate on choice of therapy for breast cancer in older women. J Am Geriatr Soc, 1995; 43:962-66.
  159. Goodwin JS, Burns E. Effect of prostaglandin E on the humoral response to a specific antigenic stimulus in human lymphocytes. Amer J Therapeutics, 1995; 2:721-24.
  160. Malone ML, Bajwatk, Battiola RJ, Fortsas M, Aman S, Solomon DJ, Goodwin JS. Variation in use of right heart catheterization at the time of coronary angiography at two community hospitals. Catheterization Diag, 1996; 37:125-30.
  161. Nattinger AB, Gottlieb MS, Hoffman RG, Walker AP, Goodwin JS. Minimal increase in use of breast-conserving surgery from 1986 to 1990. Medical Care, 1996; 34:479-89.
  162. Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Instit, 1996; 88(15):1031-38.
  163. Markides KS, Stroup-Benham CA, Goodwin JS, et al. The effect of medical conditions on the functional limitations of Mexican American elderly. Annals Epidemiol, 1996; 6(5):386-91.
  164. Sial S, Coggan A, Carroll R, Goodwin J, Klein S. Lipid kinetics during exercise in elderly and young subjects. Am J of Phys (Endo/Metab), 1996; 271: e983-e989.
  165. Nattinger AB, Hoffman RG, Shapiro R, Gottlieb MS, Goodwin JS. Effect of laws regarding disclosure of breast cancer treatment options on the adoption of breast conserving surgery. New England J Med, 1996; 335:1035-40.
  166. Willis L, Lynn R, Garry P, Wayne S, Thomas P and Goodwin JS: The impact of psychosocial factors on health outcomes in the elderly: a prospective study. J Aging and Health, 1997; 9:396-414.
  167. Goodwin JS. Chaos and the limits of modern medicine. JAMA, 1997; 278:1399-1400.
  168. Satish S, Markides KS, Zhang D, Goodwin JS: Factors influencing unawareness of hypertension among older Mexican-Americans. Prev Med, 1997; 26:645-50.
  169. Ma J, Markides KS, Perkowski LP, Stroup-Benham CA, Lichtenstein M, Goodwin JS. Impact of selected medical conditions on lower-extremity function in Mexican American elderly. Ethnicity and Disease, 1998; 8:52-59
  170. Perkowski LC, Stroup-Benham CA, Markides KS, Lichtenstein M, Angel RJ, Guralnik J, Goodwin JS. The impact of medical problems on performance-based measures of lower extremity functioning in older Mexican Americans. J Am Geriatr Soc, 1998; 46:411-18.
  171. Goodwin JS, Freeman JL, Freeman D, Nattinger AB. Geographic variations in breast cancer mortality: do higher rates imply elevated incidence or poorer survival? Am. J. Public Health, 1998; 88:458-60.
  172. Satish S, Stroup-Benham CA, Espino D, Markides KS, Goodwin JS. Undertreatment of hypertension in older Mexican Americans. J Am Geriatr Soc, 1998; 46:405-10.
  173. Carlson J, Zocchi K, Bettencourt D, Gambrel M, Zhang D, Goodwin JS. Measuring frailty in the hospitalized elderly: the concept of functional homeostasis. Am J Phys Med Rehabil, 1998; 77:252-57.
  174. Black SA, Markides KS and Goodwin JS: The association between chronic disease and depressive symptomatology in older Mexican-Americans. J Gerontol (Med. Sci.), 1998; 53:188-94.
  175. Nattinger AB, Hoffman RG, Howell A, Goodwin JS: Influence of role models on healthcare decisions: Nancy Reagan and surgery for breast cancer. JAMA, 1998; 279:762-66.
  176. Malone M, Rosen LB, Goodwin JS: Complications of acute myocardial infarction in patients > 90 years of age. Am J Cardiology, 1998; 81:638-41.
  177. Goodwin JS, Tangum MR. Battling quackery: attitudes about micronutrient supplements in American academic medicine. Archiv Intern Med, 1998; 158:2187-91.
  178. Espino DV, Lichtenstein M, Fabrizio D, Hazuda H, Loera J, Goodwin JS, Markides K.
    Correlates of prescription and over the counter medication usage among older Mexican Americans: the Hispanic EPESE study. J Am Geriatr Soc, 1998; 46:1228-34.
  179. Ostir GV, Markides, KS, Black SA, Goodwin JS: Lower body functioning as a predictor of subsequent disability among older Mexican-Americans. J Gerontol (Med. Sci.), 1998; 53:
    M491-M495.
  180. Stroup-Benham CA, Markides KS, Espino DV, Goodwin JS. Changes in blood pressure and risk factors for cardiovascular disease among older Mexican Americans from 1982-1984 to 1993-1994. J Am Geriatr Soc, 1999; 47:804-10.
  181. Carlson J, Ostir GV, Black SA, Markides KS, Rudkin L, Goodwin JS: Disability in older adults: physical activity as prevention. Behav. Med., 1999; 24:157-70.
  182. Ostir GV, Carlson J, Black SA, Rudkin L, Goodwin JS, Markides KS: Disability in older adults: Causes, prevalence and consequences. Behav. Med., 1999; 24:147-56.
  183. 183. Du XL, Freeman JL, Goodwin JS. The declining use of axillary dissection in patients with early stage breast cancer. Breast Cancer Res Treat, 1999; 53:137-44.
  184. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data. J Clin Epidemiol, 1999; 52:463-70.
  185. Goodwin JS, Black S. Aging versus disease: the opinions of older African-Americans, Hispanic Americans and non-Hispanic Whites about the cause and treatment of common medical conditions. J Am Geriatr Soc, 1999; 47: 973-979. Also reprinted in Biomedicina, 1999; 2:388-92.
  186. Goodwin JS. Geriatrics and the limits of modern medicine. N Engl J Med, 1999; 340:1283-85.
  187. Du XL, Freeman JL, Freeman DH, Syblik D, Goodwin JS. Temporal and regional variation in the use of breast conserving surgery and radiotherapy for older women with early stage breast cancer from 1983 to 1995. J.Gerontol (Med. Sci.), 1999; 54:474-78.
  188. Ontiveros JA, Black SA, Jakobi PL, Goodwin JS. Ethnic variation in attitudes toward
    hypertension in adults ages 75 and older. Preventive Medicine, 1999; 29:443-49.
  189. Freeman JL, Zhang D, Freeman DH, Goodwin JS. An approach to identifying incident breast cancer cases using Medicare claims data. J Clin Epidemiol, 2000; 53:605-14.
  190. Ostir G, Markides K, Black S, Goodwin JS. Emotional well-being predicts subsequent functional independence and survival. J Am Geriatr Soc, 2000; 48:473-78.
  191. Stroup-Benham CA, Markides KS, Black S, Goodwin JS. Relationship between low blood pressure and depressive symptomatology in the elderly. J Am Geriatr Soc, 2000; 48:250-55.
  192. Ostir G, Markides KS, Freeman DH, Goodwin JS: Obesity and health conditions in elderly Mexican Americans: The Hispanic EPESE. Established Population for Epidemiologic Studies of the Elderly. Ethnicity and Disease, 2000; 10 (1):31-38.
  193. Du XL, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Medical Care, 2000; 38:719-27.
  194. Al Snih S, Markides K, Ray L, Freeman J, Goodwin JS. Prevalence of arthritis in Mexican American elderly. Arthritis Care and Research, 2000; 13:409-16.
  195. Satish S, Ray L, Goodwin JS. The relationship between blood pressure and mortality in the oldest old. J. Am. Geriat. Soc, 2001; 49:367-74.
  196. Wu ZH, Freeman JL, Freeman DH, Greer AL, Goodwin JS. Impact of patients concerns on surgeons’ recommendations for early breast cancer. Europ. J. Cancer Care, 2001; 10:100-106.
  197. Satish S, Postigo L, Ray L, Goodwin JS. Chronic rheumatologic symptoms in a tri-ethnic sample of men and women aged 75 and older. J. Gerontol. (Med. Sci.), 2001; 56:471-76.
  198. Satish S, Ray L, Goodwin JS. Clinical significance of falling blood pressure in an elderly population. J. Clin. Epidemiol, 2001; 54:961-67.
  199. Ostir G, Markides K, Peek MK, Goodwin JS. The association between emotional well being and the incidence of stroke in older adults. Psychosomatic Medicine, 2001; 63:210-15.
  200. Ostir G, Peek MK, Markides K, Goodwin JS. The association of emotional well-being
    and future risk of myocardial infarction in older adults. Primary Psychiatry, 2001; 8:34-38.
  201. Al Snih S, Markides K, Ostir GV, Goodwin JS. The impact of arthritis on disability among older Mexican-Americans. Ethnicity and Disease, 2001; 11:11-18.
  202. Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare claims data. Journal of Clinical Oncology, 2001; 19:1455-61.
  203. Loera J, Black S, Markides K, Espino DV, Goodwin JS. The use of herbal medicines by older Mexican-Americans. J. Gerontol. Med. Sci., 2001; Vol 56A No11:M714-M718.
  204. Al Snih S, Markides K, Ray L, Goodwin JS. Impact of pain on disability of older Mexican-Americans. J. Gerontol. Med Sci., 2001; 56: M400-M404. Reprinted in BioMedicina, 2001; 4: 391-92
  205. Du X, Goodwin JS. Increase of chemotherapy use in older women with breast cancer from 1991 to 1996. Cancer, 2001; 92:730-37.
  206. Goodwin JS. Language and Medicine: Thinking and Talking about Alzheimer’s Disease. The Gerontologist, 2002; 42:293-96.
  207. Goodwin JS, Freeman JL, Mahnken JD, Freeman DH, Nattinger AB. Geographic variations in breast cancer survival among older women: Implications for quality of breast cancer care. J. Gerontol. Med Sci., 2002; 57:M401-M406.
  208. Du X, Freeman JL, Nattinger AB, Goodwin JS. Survival of women after breast conserving surgery for early stage breast cancer. Breast Cancer Res. Treat., 2002; 72:23-31.
  209. Al Snih S, Markides K, Ray L, Goodwin JS. Hand grip strength and mortality in older Mexican-Americans. J. Am. Geriatr. Soc., 2002; 50:1250-56.
  210. Goodwin JS. Developing a Geriatric business plan for an Academic medical Center. J. Am. Geriatr. Soc., 2002; 50:755-60.
  211. Raji M, Ostir GV, Markides KS, Goodwin JS. The interaction of cognitive and emotional status on subsequent physical functioning in older Mexican-Americans: Findings from the Hispanic established population for the epidemiologic study of the elderly. J. Gerontol. Med. Sci., 2002; 57A:678-82.
  212. Ostir GV, Goodwin JS, Markides KS, Ottenbacher KJ, Balfour J, Guralnik JM. Differential effects of pre-morbid physical and emotional health on recovery from acute illness. J. Am. Geriatr. Soc., 2002; 50:713-18.
  213. Ottenbacher K, Ostir G, Goodwin JS and Markides K. Diabetes Mellitus as a risk factor for hip fracture in Mexican-American older adults. J. Gerontol. Med. Sci., 2002; 57A:648-53.
  214. Greer AL, Wu ZH, Freeman JL, Goodwin JS. Bringing the patient back in: Guidelines, practice variations and the social context of medical practice. Int. J. Health Technol. Assess., 2002; 18(4):747-61.
  215. Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. Journal of Clinical Oncology, 2002; 20(24):4636-42.
  216. Randolph WM, Goodwin JS. Mahnken JD, Freeman JL. Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Annals. Intern. Med., 2002; 137:783-790.
  217. Randolph WM, Mahnken JD, Goodwin JS, Freeman JL. Using Medicare data to estimate the prevalence of breast cancer screening in older women: Comparison of different definitions to identify screening mammograms. HSR: Health Services Research, 2002; 37:1643-57.
  218. Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetic medications, diabetic complications and mortality in older Mexican Americans over a 7 year-period: Data from the Hispanic-EPESE. Diabetes Care, 2003; 26:3054-60.
  219. Al Snih S, Ostir G, Markides K, and Goodwin JS. Predictors of recovery in activities of daily living among disabled older Mexican-Americans. Aging Clin. Exp. Res., 2003; 15:315-20.
  220. Goodwin JS, Freeman JL, Satish S, Anderson E, Nattinger A. Effects of nurse case managers on the treatment of older women with breast cancer. J. Am. Geriatr. Soc., 2003; 51:1252-59.
  221. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Annals Internal Med., 2003; 138: 90-97.
  222. Lackan N, Freeman JL, Goodwin JS. Hospice use by older women dying with breast cancer between 1991 and 1996. J. Palliat. Care, 2003; 19:49-53.
  223. Goodwin JS: Embracing complexity: a consideration of hypertension in the very old. J. Gerontol. Med Sci, 2003; 58A, No. 7:653-58.
  224. Freeman JL, Goodwin JS, Zhang D, Nattinger AB, Freeman DH. Measuring the performance of screening mammography in community practice with Medicare claims data. Women and Health, 2003; 37:1-15.
  225. Ostir G, Raji M, Ottenbacher K, Markides K, Goodwin JS. Cognitive function and incidence of stroke in older Mexican-Americans. J Gerontol Med Sci, 2003; 58:531-35.
  226. Goodwin JS, Zhang D, Ostir GV: Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J. Am. Geriat. Soc., 2004; 52:106-11.
  227. Raji M, Ostir G, Markides K, Espino D, Goodwin JS. Potentially inappropriate medication use by elderly Mexican Americans: Findings from the Hispanic EPESE. Annals of Pharmacotherapy, 2003; 37:197-202.
  228. Ostir G, Eschbach K, Markides K, Goodwin JS. Neighborhood composition and depression symptoms among older Mexican-Americans. J. Epidemiol. Comm. Health, 2003; 57:987-92.
  229. Lackan N, Freeman JL, Ostir G, Goodwin JS. Decreasing variation in the use of Hospice among older adults with breast, colorectal, lung and prostate cancer. Medical Care, 2004; 42:116-22.
  230. Eschbach K, Ostir G, Patel K, Markides K, Goodwin JS. Neighborhood context and mortality among older Mexican-Americans: Is there a barrio advantage? Am. J. Pub. Health, 2004; 94:1807-12.
  231. Fisher MN, Al Shih S, Ostir GV, Goodwin JS. Positive affect and disability among older Mexican Americans with arthritis. Arthritis Care & Research, 2004; 51:34-39.
  232. Lackan NA, Ostir GV, Freeman JL, Kuo Y, Zhang DD, Goodwin JS. Hospice use by Hispanics and non-Hispanic White cancer decedents. Health Services Research, 2004; 39(4):969-983.
  233. Raji, MA, Kuo JF, Salazar JA, Satish S, Goodwin JS. Ethnic differences in antihypertensive medication use in the elderly. Annals of Pharmacotherapy, 2004; 38.
  234. Kuo YF, Raji MA, Peek MK, and Goodwin JS. Health-related social disengagement in elderly diabetic patients – association with subsequent disability and survival. Diabetes Care, 2004; 27:1630-1637.
  235. Beach RE, Newell DA, Goodwini JS. Geriatric education at University of Texas Medical Branch at Galveston. Academic Medicine, 2004; 79:S-177–S-181.
  236. Bui Q, Ostir G, Kuo Y, Freeman J, Goodwin JS. Relationship of depression to patient satisfaction: findings from the barriers to breast cancer study. Breast Cancer Research and Treatment, 2005; 89:23-28.
  237. Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS. The influence of marital status on the stage of diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Research and Treatment 2005; 93: 41-47.
  238. Eschbach K, Mahnken JD, Goodwin JS. Neighborhood composition and incidence of cancer among Hispanics in the United States. Cancer, 2005; 103:1036-1044.
  239. Shahinian VB, Kuo YF, Freeman JL, Orihuela E, Goodwin JS. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer, 2005; 103(8):1615-1624.
  240. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. New England Journal of Medicine, 2005; 352(2):154-164.
  241. Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Beholz T, Hortobagyi G, Giordano S. Cardiac Morbidity of adjuvant radiotherapy for breast cancer. J. Clin. Oncol, 2005; 23(30):7475-82.
  242. Goodwin JS. Aronow’s “Should the NCEP III guidelines be changed in elderly and younger person at high risk for cardiovascular events? What do we do for the very old? J Gerontology Series A-Biological Sciences & Medical Science, 2005; 60(5):593-594.
  243. Jennings-Sanders A, Kuo Y, Anderson ET, Freeman JL, Goodwin JS. How do nurse case managers care for older women with breast cancer? Oncology Nursing Forum, 2005; 32(3):625-32.
  244. Nguyen-Oghalai, T.U., Ottenbacher, K.J., Linn, R.T., Granger, C.V., Goodwin, J.S. Impact of osteoarthritis on rehabilitation from stroke. Arthritis & Rheumatism, 2005, 53(3):383-387.
  245. Geraci J, Escalante CP, Freeman JL, Goodwin, JS. Comorbid disease and cancer: the need for more relevant conceptual models in health services research. J. Clin. Oncol., 2005, 23:7399-7404.
  246. Al Snih S, Fisher MN, Raji MA, Markides KS, Ostir GV, Goodwin JS. Diabetes Mellitus and incidence of lower body disability among older Mexican Americans. J. Gerontology: Med Sci. 2005; 60A:1152-56.
  247. Al Snih S, Raji M, Markides K, Ottenbacher K, Goodwin JS. Weight change and lower body disability among Mexican Americans. J. Am. Geriatric Soc. 2005; 53:1730-1737.
  248. Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of Cardiac Death after Adjuvant Radiotherapy for Breast Cancer. J. Nat. Cancer Instit. 2005; 97(6):419-24.
  249. Ostir GV, Goodwin JS. High anxiety is associated with an increased risk of death in an older tri-ethnic population. J. Clin. Epidemiol, 2006; 59:534-540.
  250. Nguyen TU, Ottenbacher KJ, Granger CV, Goodwin JS. Impact of osteoarthritis on the rehabilitation of patients following a stroke. Arthritis Rheum, 2006; 55(6):920-4.
  251. Ostir GV, Goodwin JS. Anxiety in persons 75 and older: findings from a tri-ethnic population. Ethn Dis 2006; 16:22-27.
  252. Giordano, SH, Duan ZG, Kuo, YF, Hortobagyi GN, Fremean JL, Goodwin JS. Impact of a scientific presentation on community treatment patterns for primary breast cancer. J. Nat. Cancer Instit., 2006; 98(6):382-88.
  253. Amador LF, Al Snih S, Markides K, Goodwin JS. Weight change and mortality among older Mexican Americans. Aging Clin Exp Res. 2006; 18:196-204.
  254. Luo RL, Giordano SH, Freeman JL, Zhang D, Goodwin JS. Referral to Medical Oncology: A Crucial Step in the Treatment of Older Patients with Stage III Colon Cancer. The Oncologist, 2006; 11 (9):1025-1033.
  255. Giordano SH, Lee A, Kuo YF, Freeman JL, Goodwin JS. Late gastrointestinal toxicity after radiation for prostate cancer. Cancer, 2006; 107 (2):423-432.
  256. Giordano SH, Zhang DD, Kuo Y, Freeman JL, Goodwin JS. Use and outcomes of Adjuvant Chemotherapy in older Women with Breast Cancer. J. Clin. Oncol., 2006; 24(18):2750-2756.
  257. Eschbach K, Markides K, Goodwin JS. Ascertainment of Hispanic ethnicity on the California death certificates: Implications for the explanation of the Hispanic mortality advantage. Am. J. Public Health, 2006, Dec; 96(12):2209-15.
  258. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the “Androgen Deprivation Syndrome” in men receiving androgen deprivation for prostate cancer. Archives of Internal Medicine, 2006; 166: 465-71.
  259. Reyes C, Freeman J, Pelaez M, Markides K, Goodwin J. Mammography use among older Women of seven Latin American and Caribbean cities. Preventive Medicine 2006; 42:375-380.
  260. Caban ME, Freeman JL, Zhang DD, Ostir G, Hatch SS, Goodwin JS. The relationship between depressive symptoms and shoulder mobility among older women: Assessment at one year after breast cancer diagnosis. Journal of Clinical Rehabilitation, 2006; 20 (6):513-522.
  261. Smith SM, Mathews Oliver SA, Zwart SR, Kelly PA, Goodwin JS, Dyer CB. Nutritional status assessment of the self-neglecting elderly, J. Nutrit, 2006; 136 (10):2534-2541
  262. Reyes-Ortiz CA, Goodwin JS, Freeman JL, Kuo YF. Socioeconomic status and survival in older patients with Melanoma. J Am Geriat Soc, 2006; 54 (11):1758-1764.
  263. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Determinants of androgen deprivation use for prostate cancer: role of the urologist. J. Natl. Cancer Instit, 2006; Jun 21; 98 (12): 839-45.
  264. Al Snih S, Markides KS, Ray LA, Freeman JL, Ostir CV, Goodwin JS. Predictors of health care utilization among older Mexican Americans. Ethnicity and Disease, 2006; 12 (3): 640-645
  265. Tan A, Freeman DH, Goodwin J, Freeman J. Variation in false-positive rates of mammography reading amount 1067 radiologist: a population-based assessment. Breast Cancer Res Treat, 2006; 100 (3):309-318.
  266. Sharma G, Goodwin JS. Effect of aging on respiratory system physiology and immunology. Clinical Interventions in Aging, 2006; 1(3):253-260
  267. Amador LF, Al Snih S, Markides KS, Goodwin JS. Body mass index and change in blood pressure over a 7-year period among older Mexican Americans. Clinical Interventions Aging; 2006;3:275-282.
  268. Rotkiewicz AM, Al Snih S, Kuo J, Raji MA, Markides KS, Goodwin JS. Cognitive decline in older Mexican Americans with diabetes. JNMA, 2006; 98:1840-1847.
  269. Luo R, Giordano SH, Zhang DD, Freeman JL, Goodwin JS. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer, 2007; 109(5):975-982.
  270. Kaushik VP, Al Snih S, Raji MA, Markides KS, Goodwin JS. Factors associated with seven-year incidence of diabetes complications among older Mexican Americans. Gerontology, 2007; 53:194-199.
  271. Goodwin JS, Nguyen T, Kuo YF, Ottenbacher K. Epidemiology of Medicare Abuse: The power wheelchair epidemic. J. Am. Geriatr. Soc, 2007; 55:221-226.
  272. Al Snih S, Ottenbacher KJ, Markides KS, Kuo YF, Eschbach K, Goodwin JS. The effect of obesity on Disability vs. Mortality in Older Americans. Archives of Int. Med, 2007; 167:774-780
  273. Riall TS, Stager VM, Nealon WH, Townsend CM Jr, Kuo Y, Goodwin JS, Freeman JL. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. J. Am. Coll. Surg, 2007 May; 204(5):803-13.
  274. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. Chronic herpes virus reactivation occurs in aging. Experimental Gerontology, 2007: 42:563-570
  275. Wilkinson GS, Kuo YF, Freeman JL, Goodwin JS. Intravenous Bisphosphonate Therapy and Inflammatory Conditions or Surgery of the Jaw: A Population-Based Analysis. J. Natl. Cancer Instit., 2007;Jul 4;99(13):1016-24
  276. Burns EA, Fleming R, Wasstaff DA, Goodwin JS. Relationship among affective and behavioral stress outcomes in Alzheimer’s caregivers. J Applied Social Psychol, in press.
  277. Dyer CB, Goodwin JS, Vogel M, Regev C, Pickens S, Burnett J, Baum GP, Kelly P. Characterizing self-neglect: a report of over 500 cases seen by a geriatric medicine team. Am. J. Public Health, 2006; in press.
  278. Eschbach K, Stimpson JP, Kuo YF, Goodwin JS. Mortality of Hispanic immigrants and U.S.-born Hispanics at younger ages: a re-examination of recent patterns. Am. J. Public Health, in press
  279. Goodwin JS, Kuo YF, Shahinian V. Survival of older men after a diagnosis of prostate cancer. Submitted.
  280. Peek MK, Cutchin MP, Freeman DH, Perez NA, Goodwin JS. Perceived health change in the aftermath of a petrochemical accident: An examination of predisposing, precipitating, and perpetuating factors. J. Epidemiology and Community Health.
  281. Peek MK, Cutchin MP, Freeman DH, Perez NA, Goodwin JS. Perceived Health Change in the Aftermath of a Petrochemical Accident: An Examination of Pre-Accident, Within-Accident, and Post-Accident Variables. J. Epid. Comm. Health, 2007, in press.
  282. Shahinian VB, Kuo YF, Goodwin JS. Gonadotropin-releasing hormone agonist use in men
    without cancer registry diagnosis of prostate cancer. Submitted.
  283. Shahinian V, Kuo YF, Freeman JL, Orihuela E, Goodwin JS. Urologist characteristics
    predict use of androgen deprivation therapy for prostate cancer. J. Clin. Oncol., in press.
  284. Wang J, Freeman JL, Kuo YF, Goodwin JS. Temporal trends and predictors of perioperative
    chemotherapy use in elderly patients with resected non-small cell lung cancer. Cancer, in press.

INVITED REVIEWS, EDITORIALS, AND BOOK CHAPTERS

  1. Goodwin JS: The use of intracranial stimulation in behavioral modification with several types of rodents. Amherst College honors thesis.
  2. Lovenberg W, Goodwin JS and Wallace EF: Molecular properties and regulation of dopamine-B-hydroxylase. In: Neurobiological Mechanisms of Adaptation and Behavior, AJ Mandell editor, New York, Raven Press, 1975, pp 77-93.
  3. Goodwin JS: Cimetidine and delayed hypersensitivity (letter). Lancet, 1978; 1:934.
  4. Smith EB, Mason WB and Goodwin JS: Prostaglandins and actinic cancer (letter). Lancet, 1978; 1:561.
  5. Goodwin JS and Williams RC, Jr: Suppressor cells-a recent conceptual epidemic (editorial). J Clin Lab Immunol, 1979; 2:89-91.
  6. Goodwin JS and Webb DR: Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol, 1980; 15:106-22.
  7. Goodwin JS, Husby G and Williams RC, Jr: Prostaglandin E and cancer growth. Cancer Immunol Immunother, 1980; 8:3-7.
  8. Vogel AV, Goodwin JS and Goodwin JM: The therapeutics of placebo. Am Fam Physician, 1980; 22(1):105-109.
  9. Froelich CJ, Goodwin JS, Bankhurst AD and Williams RC, Jr: Pregnancy, a temporary fetal graft of suppressor cells in autoimmune disease? (editorial) Am J Med, 1980; 69:329-31.
  10. Goodwin JS: Prostaglandin synthetase inhibitors as immuno-adjuvants in the treatment of cancer. J Immunopharmacol, 1980; 2:397-424.
  11. Goodwin JS: Placebo treatment. Behavioral Med, 1980; 7:12.
  12. Goodwin JS: Prostaglandin E and cancer growth: Potential for immunotherapy with prostaglandin synthetase inhibitors. In: Augmenting Agents in Cancer Therapy, EM Hersh, MA Chirigos, MJ Mastrangelo, Editors. New York, Raven Press, 1981, pp 393-415.
  13. Goodwin JS: Prostaglandins and host defense in cancer. In: Prostaglandins in Health and Disease, RP Robertson editor, Med Clin North Am, 1981; 65:829-44.
  14. Ceuppens J and Goodwin J: Prostaglandins and the immune response to cancer. Anticancer Res, 1981; 1:71-78.
  15. Goodwin JS: Suppressor cells: An introduction. In: Suppressor Cells in Human Disease, JS Goodwin Editor, New York, Marcel Dekker, 1981, pp 1-29.
  16. Goodwin JS and Webb DR: Regulation of the immune response by prostaglandins. In: Suppressor Cells in Human Disease. JS Goodwin, editor, New York, Marcel Dekker, 1981, pp 99-135.
  17. Zeisel SH, Garry PJ, Brigida M, Magil SG, Goodwin JS and Alvarez N: Serum choline concentrations in aged humans. In: Alzheimers Disease: A Report of Progress in Research, S. Corkin et al., Editors, New York, Raven Press, 1982, pp 45-47.
  18. Goodwin JM and Goodwin JS: Le placebo: Histoire d'un concept. Cahiers Medicaux, 1982; 7:1325-27.
  19. Goodwin JS and other members of National Institute on Aging Research Planning Panel: A National Plan for Research on Aging, NIH Pub #82-2453, 1982.
  20. Ceuppens JL and Goodwin JS: Prostaglandins and cancer growth. In: Nutrients as Modulators of Cancer Growth, Amsterdam, Elsevier/North Holland, 1982.
  21. Goodwin JS and Ceuppens JL: Effect of non-steroidal anti-inflammatory drugs on immune function. Sem Arthritis Rheum, 1983; 13(suppl):134-43.
  22. Goodwin JS: Mechanism of action of non-steroidal anti-inflammatory agents. In: The State of the Art in Arthritis Therapy (Special Report). Postgrad Med, May 1983, pp23-31.
  23. Goodwin JS and Ceuppens JL: Regulation of the immune response by prostaglandins. J Clin Immunol, 1982; 3:295-315.
  24. Goodwin JS: The pathogenesis and treatment of rheumatoid arthritis. Mediguide to Inflammatory Diseases, 1983; 1(1):1-8. New York. Lawrence DellaCorte.
  25. Goodwin JS: Polymyalgia rheumatica. Mediguide to Inflammatory Diseases, 1983; 2(4)1-8, New York, Lawrence DellaCorte.
  26. Gualde N and Goodwin JS: L'immunologie du vieillissement. La Revue de Medicine Interne, 1983; 4:237-45.
  27. Goodwin JS, Ceuppens JL and Gualde N: Control of immune response in humans by prostaglandins. In: Therapeutic Control of Inflammatory Diseases, I Otterness, RN Capetola and S Wong editors (Advances in Inflammation Research; v. 7) New York, Raven Press, 1984, pp 79-92.
  28. Goodwin JS: Mechanisms of action of non-steroidal anti-inflammatory agents. Am J Med, 1984;77(1A):57-64.
  29. Goodwin JS, Ceuppens JL and Rodriguez MA: Inhibition of rheumatoid factor production by non-steroidal anti-inflammatory drugs. Inflammation, 1984; 8(suppl):S49-S55.
  30. Ceuppens JL and Goodwin JS: Prostaglandins as modulators of T- and B-lymphocyte function. In: Immune Modulation Agents and Their Mechanisms. RL Fenichel and MA Chirigos, editors. New York, Marcel Dekker, 1984, pp 627-48.
  31. Goodwin JS: Immunology. In: Geriatric Medicine (Vol. 1) CK Cassell and JR Walsh, editors. New York, Springer-Verlag, 1984, pp 299-310.
  32. Koster FT, Goodwin JS and Williams JC: Immunoregulation in acute and chronic Q fever. Microbiology 1984, L Lieve and D Schlessinger, editors. Washington, D.C.; American Society for Microbiology, 1984, pp 282-84.
  33. Goodwin JS: Giant cell arteritis. Mediguide to Inflammatory Diseases 3(1):1-8, 1984. New York, Lawrence DellaCorte. 1984.
  34. Goodwin JS: Immunologic effects of non-steroidal anti-inflammatory drugs. Am J Med, 1984; 77(4B):7-15.
  35. Goodwin JS: On nutrition and memory. Executive Health Report 21(1) October, 1984. Rancho Santa Fe, California; Executive Health Publications.
  36. Goodwin JS: Reconditi pensieri, Gli anziani in ospedale. Giornale de Gerontologia, 1984; 32:453-454.
  37. Goodwin JS: Citation classic: Prostaglandin-producing suppressor cells in Hodgkin's disease. Current Contents, 1985; 28:17.
  38. Goodwin JS and Ceuppens JL: Prostaglandins, cellular immunity and cancer. In: Prostaglandins and Immunity, JS Goodwin editor, Boston, Martinus Nijhoff, 1985, pp 1-34.
  39. Ceuppens JL and Goodwin JS: Control of antibody and auto-antibody production by prostaglandin E. In: Prostaglandins and Immunity, JS Goodwin editor, Boston, Martinus Nijhoff, 1985, pp 99-121.
  40. Gualde N, Aldigier JC, Mexmain S and Goodwin JS: Regulation of the immune response by eicosanoid acids. In: Prostaglandins and Immunity, JS Goodwin, editor, Boston, Martinus Nijhoff, 1985, pp 147-60.
  41. Rosenthal M and Goodwin JS: Cognitive effects of nutritional deficiency. In: Advances in Nutritional Research, HH Drapter, editor, New York, Plenum Press 1985, pp 71-100.
  42. Ceuppens JL and Goodwin JS: Immunological effects of non-steroidal anti-inflammatory drugs with particular reference to the role of prostaglandin. In: Anti-Inflammatory and Anti-Rheumatic Drugs, KD Rainsford, editor, New York, CRC Press, 1985, pp 90-105.
  43. Garry PJ, Hunt WC and Goodwin JS: Changes in dietary patterns over a four year period in an elderly population. In: Proceedings of the XIII International Nutrition Congress, TG Taylor and NK Jenkins, eds., John Libbey, London, 1985, pp 713-15.
  44. Goodwin JS: Immunological effects of non-steroidal anti-inflammatory agents. In: Immunological Disorders of the Adult, P Katz and L Corman editors, (Med Clin North Am). Philadelphia, WB Saunders, 1985, pp 793-804.
  45. Gualde N and Goodwin JS: Induction of suppressor T cells in vitro by arachidonic acid metabolites of the lipoxygenase pathway. In: Prostaglandins, Leukotrienes and Lipoxins, JM Bailey editor, New York, Plenum Press, 1985, pp 565-75.
  46. Garry PJ, Hunt WC and Goodwin JS: Longitudinal assessment of iron status in an elderly population. In: Nutrition, Immunity and Illness in the Elderly, RK Chandra, editor, Pergammon Press, 1985, pp 77-83.
  47. Gualde N, Mexmain S, Aldigier J and Goodwin JS: Eicosanoids and the immune response. In: Eicosanoids and Cancer, J Craste de Paulet, editor, New York, Raven Press 1986, pp 155-67.
  48. Goodwin JS and Goodwin JM: Impossibility in Medicine. In: DJ Davis and D Park, editors. No Way: The Nature of the Impossible. WH Freeman and Co., 1986, New York.
  49. Goodwin JS: Role of Leukotriene B4 in T cell activation. Transplantation Proc., 1986; 18: supplement, pp 49-56.
  50. Goodwin JS: Regulation of T cell activation by leukotriene B4. Immunological Research, 1986; 5:233-48.
  51. Behrens T and Goodwin J: Role of Platelet activating factor in B and T cell activation. In: The Role of Platelet Activating Factor in the Immune Response, edited by P. Braquet. FOUNDATION IPSEN, PARIS, 1987.
  52. Goodwin JS: Toxicity of non-steroidal anti-inflammatory drugs (editorial). Archiv Int Med, 1987; 147:34-35.
  53. Goodwin JS and Glay GA: Effects of misoprostol on immune function in elderly subjects. Prostaglandins, 1987; 33(suppl):61-67.
  54. Goodwin JS: Regulation of T cell activation by leukotriene B4. In: Lipid Mediators in the Immunology of Shock, edited by M. Paubert-Braquet, Plenum Press, New York, 1987, pp 469-482.
  55. Goodwin JS and Gary PJ (principal authors): Nutrition in the elderly. Chapter in The Surgeon General's Report on Nutrition in America, 1988, U.S. Government Printing Office, Washington, DC.
  56. Benveniste J, Thomas Y and Goodwin JS: Phospholipid-derived mediators of the immune response; In: Lymphocyte activation and differentiation, edited by C. Mani. Walter De Gruyter and 10, Berlin, pp 599-608, 1988.
  57. Goodwin J and Behrens T: Role of leukotrienes in B and T cell activation, In: Biology of the Leukotrienes, edited by R.D. Krell and R. Levi. Annals of the New York Academy of Sciences, 1988; 524:201-208.
  58. Behrens T and Goodwin J: Glucocorticosteroids. In: The Pharmacology of Lymphocytes, edited by M.A. Bray and J. Morley, Springer-Verlag, Berlin, 1988, 425-40.
  59. Goodwin JS: Teaching preventive medicine to geriatric patients and their physicians: The concept of the edge. Mediguide to Inflammatory Disease, 1988; 7:1-5.
  60. Goodwin JS and Csuka, ME: Bone and joint disease in the elderly. In: Geriatrics for the Internist, H Rothschild, editor, C.V. Mosby, New York, 1988.
  61. Behrens T and Goodwin JS: Regulation of the humoral immune response by eicosanoids and platelet activating factor. In: New Trends in Lipid Mediators Research, volume 1, edited by P. Brauet, Karger AG, Basel, 1988, pp 64-75.
  62. Kucharz E and Goodwin JS: Serum IL-2 inhibitors, Life Sciences, 1988; 42:1485-91.
  63. Goodwin JS: Foreword. In: Prostaglandins, Leukotrienes and the Immune Response, by J.L. Ninnemann. Cambridge Univ. Press, 1988. ix-x.
  64. Behrens T and Goodwin JS: Glucocorticoids. In: Arthritis and Allied Conditions, DJ McCarty, editor, 11th edition, Lea and Febiger, Philadelphia, 1989, pp 604-21.
  65. Samet J and Goodwin JS: Patterns of cancer care for non-Hispanic whites, Hispanics, and American Indians in New Mexico. In: Cancer in the Elderly. R Yancik and J Yates, editors, Springer, New York, 1989, pp 108-26.
  66. Behrens T and Goodwin JS: Control of the immune response by arachidonic acid metabolites. Agents and Actions, 1989; 26:15-21.
  67. Goodwin JS: Social, psychological and physical factors affecting the nutritional status of elderly subjects: Separating cause from effect. Am J Clin Nutri, 1989; 50:1201-09.
  68. Goodwin JS: Immunologic effects of anti-inflammatory drugs. Current Opinion in Immunology, 1989; 2:264-68.
  69. Goodwin JS: Summary Comments to Epidemiologic and Methodologic Problems in Determining Nutritional Status of Older Persons. Am J Clin Nutrit, 1989; 50:1234-35.
  70. Csuka ME and Goodwin JS: Rheumatoid Arthritis. In: Principles of Geriatric Medicine and Gerontology. Edited by W. Hazzard, R. Andres, E. Bierman and J. Blass, McGraw Hill, New York, 1990, pp 869-79.
  71. Burns E and Goodwin JS: Immunology and Infectious Disease. In: Geriatric Medicine, edited by J. Walsh and C. Cassel. Springer-Verlag, New York, 1990, pp 312-29.
  72. Goodwin JS: Citation Classic: Regulation of the Immune Response by Prostaglandins. Current Contents, 1990; 33:21.
  73. Goodwin JS, Behrens T: Humoral factors in immune suppression after injury. In: Shock, Sepsis and Organ Failure, edited by G. Schlag, H. Redland, J. Siegel, Springer Verlag, Berline, 1990, pp 329-50.
  74. Behrens T and Goodwin JS: Corticosteroids. In: Sports-Induced Inflammation, W.B. Leadbetter et al. (eds)., Am. Acad. Orthop. Surg., Park Ridge, IL, 1990, pp405-20.
  75. Goodwin JS: Review of "Anti-Inflammatory Steroid Action: Basic and Clinical Aspects". Arthritis and Rheumatism, 1990; 33:1488.
  76. Goodwin JS and Burns E: Aging, Nutrition and Immune Function. Clinics in Applied Nutrition, 1990; I:82-91.
  77. Goodwin JS: Pharmacologic manipulation of the immune response. In: Basic and Clinical Immunology, Lange Medical Publications, D.P. Sites and A.I. Terr (eds), 1991, pp 786-94.
  78. Goodwin JS: Surviving Continuing Medical Education: A self-help manual for CME directors and their audiences. Wisc Med J., 1991; 90:12-13.
  79. Goodwin JS: Are prostaglandins proinflammatory, anti-inflammatory, both or neither? J. Rheumatology, 1991; 18:26-29.
  80. Burns EA and Goodwin JS: Immunodeficiency and Aging. L'Annee Gerontologie, 1991. J. Albarede and P. Vellas (eds), Serdi Publications, Paris, pp 19-30.
  81. Drinka PJ and Goodwin JS: Prevalence and Consequences of Vitamin Deficiency in the Nursing Home: a critical review. J Am Geriat Soc, 1991; 39:1008-17.
  82. Goodwin JS and Samet JM: Factors affecting diagnosis and treatment of cancer in the elderly. In: Geriatric Oncology L.D. Balducci and W. Ershler (eds). J.P. Lippincott, New York, 1992, pp 42-52.
  83. Goodwin JS: Progress in Gerontology: Polymyalgia rheumatica and temporal arteritis. J Am Geriat Soc, 1992; 40:515-25.
  84. Goodwin JS and Burns EA: The Aging Immune System. In: J. Morley (ed). Cowdry's Geriatrics, Manning Co., St. Louis, 1993.
  85. Silliman RA, Balducci L, Goodwin JS, Holmes FF, and Leventhal EA: Breast Cancer in Old Age: What we Know, Don't Know, and Do. J. Nat. Cancer Instit., 1993; 85:190-99.
  86. Goodwin JS and Samet JM: Care Received by Older Women Diagnosed with Breast Cancer. Cancer Control, 1994; 1:313-19.
  87. Nattinger A, and Goodwin JS: Regional and hospital-based variation in the treatment of early breast cancer. Cancer Control, 1994; 1:334-38.
  88. Goodwin JS. Anti-inflammatory drugs; In: Basic and Clinical Immunology, 8th edition. Lange Medical Publications, DP sites, AI Terr and TG Parslow, eds, 1994, pp 786-94.
  89. Goodwin JS and Burns EL. Aging, nutrition and immunity; In: Aging Immunity and Infection, Springer Publishing Co, D.C. Powers, RM Coe, J Morley, eds, 1994, pp 223-46.
  90. Burns EL and Goodwin JS. Aging, nutrition and immunity; In: Nutrition and Clinical Immunology, CRC press, GL Blackburn, L. Kabbash, SJ Bell, eds, 1994, pp 57-72.
  91. Goodwin JS. The statistics of Robert Kellner: a glossary of terms. Perspect. Biol. Med., 1994;37: 285-86.
  92. Goodwin JS. Introduction. In “A Festshrift in honor of Ralph C. Williams.” Clin Immunol, 1994; 70:1-2.
  93. Goodwin JS. Nonsteroidal anti-inflammatory drugs; In: Clinical Immunology, Mosby, St. Louis, RR Rich, editor, 1995, pp 1959-67.
  94. Goodwin JS, Brodwick M. Diet, Aging and Cancer. Clinics in Geriatric Medicine, 1995; 11: 577-89.
  95. Goodwin JS. Decreased immunity and increased morbidity in the elderly. Nutrit. Rev., 1995; 53: S41-46.
  96. Burns EA, Goodwin JS. Immunology of Aging. In: Geriatric Oncology, edited by L. Balducci, G. Lyman, W. Ershler, Harwood. 1996.
  97. Goodwin JS. Factors affecting the diagnosis and treatment of older persons with cancer. In: Geriatric Oncology, edited by L. Balducci, G. Lyman, W. Ershler, Harwood. 1996.
  98. Burns E and Goodwin JS. Immunology. In: Geriatric Medicine, 3rd edition, edited by C. Cassel, H. Cohen, E. Larson, D. Meier, N. Resnick, L. Rubenstein, and L. Sorenson. Springer Verlag, New York, 1997, pp 585-99.
  99. Burns EA, Goodwin JS. Immunodeficiency of aging. Drugs and Aging, 1997; 11:374-97.
  100. Goodwin JS. Jabs and Jibes: Switching sides. Lancet, 1998; 351:1070.
  101. Goodwin JS. Jabs and Jibes: E-mail: Fighting back. Lancet, 1999; 353:1372.
  102. Goodwin JS. Jabs and Jibes: Being a doctor or being a son. Lancet, 1999; 354:1484.
  103. Goodwin JS. Handbook for mortals: Guidance for those facing serious illness (book review). WJM, 1999; 171:282-283.
  104. Goodwin JS. Jabs and Jibes: Airports. Lancet, 2000; 355:1286.
  105. Goodwin JS. Jabs and Jibes: In praise of insecurity. Lancet, 2000; 355:2086.
  106. Goodwin JS. Nobility. Ann Int Med, 2001; 134:621-22.
  107. Goodwin JS. Jabs and Jibes: Making doctors. Lancet, 2001; 357:816.
  108. Imboden JB, Goodwin JS, Davis J, Wofsy D. Immunosuppressive, anti-inflammatory and
    immunomodulatory therapy. In: Medical Immunology, 10th edition. T Parslow, D Sites, A Terr, J Imboder, eds. McGraw Hill, New York, 2001.
  109. Goodwin JS. Jabs and Jibes: Narcissus drowned. Lancet, 2001; 357:1376.
  110. Goodwin JS. Jabs and Jibes: Life lessons from the Texas Kitchen. Lancet, 2001; 358:772.
  111. Goodwin JS. Jabs and Jibes: Galveston dogs. Lancet, 2001; 358:1282.
  112. Goodwin JS. Jabs and Jibes: Breaking bad news. Lancet, 2002; 360:958.
  113. Goodwin JS. Jabs and Jibes: Ambling towards Nirvana. Lancet, 2002; 359:1358.
  114. Goodwin JS. Jabs and Jibes: Hurricanes. Lancet, 2002; 360:1260.
  115. Goodwin JS. Lifeline. Lancet, 2002; 359:2286.
  116. Burns EA, Goodwin JS. Immunology. In: Geriatric Medicine, 4th edition, edited
    by C. Cassel, H. Cohen, E. Larson. Springer Verlag, New York, in press
  117. Burns EA, Goodwin JS. The effect of aging on immune function. In: Principles and Practices of Geriatric Surgery, edited by R.Rosenthal, M.Zenilman; Springer-Verlag, New York, in press.
  118. Goodwin JS. Jabs and Jibes: First in his class. Lancet, 2003; 361: 356.
  119. Goodwin JS. Jab and Jibes: God only knows. Lancet, 2003; 361.
  120. Goodwin JS. Jabs and Jibes: Lost at Sea. Lancet, 2003; 362:1164.
  121. Raji MA, Goodwin JS. Perception of causes and treatment of common diseases in Black, non-Hispanic white, and Hispanic Americans aged 75 years and older. Physicians and Patients, 2003; 1:20-22.
  122. Goodwin JS. Commentary – The struggle to relate epidemiology to real people – Author’s response to commentaries. J Gerontol. Series A – Biological Sci. and Med Sci., 2003; 58: 669-670.
  123. Goodwin JS. Incorporating disability into population-level models of health change at older ages –Commentary. 2004; 59: 605-606.
  124. Burns EA, Goodwin JS. Effects of aging on immune function. J. Nutr. Health, Aging, 2004; 8:9-19.
  125. Goodwin JS, Osborne C. Factors affecting the diagnosis and treatment of older persons with cancer. In: Comprehensive Geriatric Oncology, 2nd Edition, L. Balducci, G. Lyman, W. Ershler, M. Exterman, eds. Harwood Academic Publications, 2004; 56-66.
  126. Burns EA, Goodwin JS. Immunology of Aging. In: Comprehensive Geriatric Oncology, 2nd Edition, L. Balducci, G. Lyman, W. Ershler, M. Exterman, eds. Harwood Academic Publications, 2004; 158-170.
  127. Reyes-Ortiz C, Goodwin JS, Freeman JL, The effect of socioeconomic factors on incidence, stage at diagnosis, and survival of cutaneous melanoma. Med. Sci. Mon. 2005; 11: 163-172.
  128. Amador LF, Goodwin JS. Postoperative delirium in the older patient. J. Am. Coll. Surg. 2005; 200:767-773.
  129. Raji M, Goodwin JS. Biology of Aging. In: Geriatric Otolaryngology. KH Calhoun and DE Eibling, eds. CRC Press, 2006. pp 17-24.
  130. Sharma G, Goodwin JS. Effect of aging on respiratory system physiology and immunology. Clin. Interventions in Aging. 2006; I(3) 253-260.
  131. Eschbach K, Al Snih S, Markides KS, Goodwin JS. Disability and Active Life Expectancy of Older U.S.-and Foreign-Born Mexican Americans. The Health of Aging Hispanics, 2007; 40-49.

BOOKS

  1. Goodwin JS (editor). Suppressor Cells in Human Disease, New York, Marcel Dekker, 1981.
  2. Goodwin JS (editor). Prostaglandins and Immunity, Boston, Martinus Nijhoff, 1985.